Authors: Spiro, TP Liu, L Majka, S Haaga, J Willson, JKV Gerson, SL

Citation: Tp. Spiro et al., Temozolomide: The effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O-6-alkylguanine-DNA-alkyltransferase, CLIN CANC R, 7(8), 2001, pp. 2309-2317

Authors: Liu, L Spiro, TP Qin, XS Majka, S Haaga, J Schupp, J Willson, JKV Gerson, SL

Citation: L. Liu et al., Differential degradation rates of inactivated alkyltransferase in blood mononuclear cells and tumors of patients after treatment with O-6-benzylguanine, CLIN CANC R, 7(8), 2001, pp. 2318-2324

Authors: Dowlati, A Hoppel, CL Ingalls, ST Majka, S Li, XL Sedransk, N Spiro, T Gerson, SL Ivy, P Remick, SC

Citation: A. Dowlati et al., Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days, J CL ONCOL, 19(8), 2001, pp. 2309-2318

Authors: Majka, S McGuire, P Colombo, S Das, A

Citation: S. Majka et al., The balance between proteinases and inhibitors in a murine model of proliferative retinopathy, INV OPHTH V, 42(1), 2001, pp. 210-215

Authors: Spiro, TP Gerson, SL Liu, LL Majka, S Haaga, J Hoppel, CL Ingalls, ST Pluda, JM Willson, JKV

Citation: Tp. Spiro et al., O-6-benzylguanine: A clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directrd DNA repair, CANCER RES, 59(10), 1999, pp. 2402-2410